Application of poecilobdella manillensis polypeptide in whitening and anti-aging
Through the experiment on inhibiting tyrosinase activity of phenanthirs polypeptide and its effect on reactive oxygen and lipofuscin in Caenorhabditis elegans, the existing whitening products failed to fully utilize the anticoagulant activity of phenanthirs. The problem has achieved significant whitening and anti-aging effects, demonstrating the application potential of phenanthrene polypeptide in whitening and anti-aging.
Patent Information
- Application Number
- CN202411259297.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-09
- Publication Date
- 2024-11-08
AI Technical Summary
Existing whitening products have not yet fully utilized the anticoagulant activity of phenanthirs and have not effectively exerted their whitening and anti-aging potential.
By conducting experiments on inhibiting tyrosinase activity on phenanthirs polypeptide and determining its effect on reactive oxygen and lipofuscin deposition in C. elegans, the application of phenanthirs polypeptide in whitening and anti-aging is provided, with the preferred concentration. The range is 1.8-6.4 mg/mL, which significantly inhibits tyrosinase activity and reduces ROS and lipofuscin levels in nematodes.
The phenanthirs polypeptide inhibited tyrosinase activity at a concentration of 3.2 mg/mL, and the dosing concentrations of 0.58 mg/mL were significantly reduced. Lipofuscin deposition and ROS levels in nematodes prove their significant effects in whitening and anti-aging.
Smart Images

Figure CN118903365A_ABST
Abstract
Description
Technical Field
[0001] The present application relates to the technical field of leech polypeptides, and in particular to the application of leech polypeptides in whitening and anti-aging. Background Art
[0002] The Philippine leech is the dried body of the Philippine leech Poecilobdella manillensis, a Hirudinidae animal, commonly known as the golden-edged leech. It is the largest species among the common blood-sucking leeches. Traditional Chinese medicine believes that it can break blood and promote menstruation, remove blood stasis and eliminate symptoms, and can be used to treat blood stasis, amenorrhea, hemiplegia due to stroke, lumps, and sprains. It is reported that the anticoagulant active ingredients of the Philippine leech are mainly hirudin and hirudin, which are basically the same as the main active ingredients of leeches, and the anticoagulant activity of the Philippine leech is stronger than that of the leech (Whitmaniapigra Whitman) and leech (Hirudonippaonica Whitman) recorded in the Chinese Pharmacopoeia. Therefore, in recent years, the research and application of the anticoagulant activity of the Philippine leech has attracted widespread attention.
[0003] Traditional Chinese medicine mainly exerts whitening effects by improving skin microcirculation, inhibiting melanin formation and anti-oxidation. At present, whitening products with anticoagulant activity of hirudin (improving skin microcirculation) have been reported, but no whitening products have been launched for leeches, whose anticoagulant effect is much stronger than that of leeches. The following is an experiment to inhibit tyrosinase activity of leech polypeptides and to measure the effects of leech polypeptides on reactive oxygen species (ROS) and lipofuscin deposition in Caenorhabditis elegans to evaluate the whitening and anti-aging effects of leech polypeptides, providing a more comprehensive theoretical basis for the development of leech polypeptides. Summary of the invention
[0004] The purpose of the present application is to provide an application of leech polypeptide in whitening and anti-aging, to conduct an experiment on inhibiting tyrosinase activity of leech polypeptide, to measure the effect of leech polypeptide on reactive oxygen species (ROS) and lipofuscin deposition in Caenorhabditis elegans, and to evaluate the whitening and anti-aging effects of leech polypeptide.
[0005] The present application provides the application of leech polypeptide in whitening and anti-aging.
[0006] Preferably, the leech polypeptide has tyrosinase inhibitory activity at a concentration of 1.8-6.4 mg / mL.
[0007] Preferably, the leech polypeptide has tyrosinase inhibitory activity at a concentration of 3.2 mg / mL.
[0008] Preferably, the administration concentration of 0.1 mg / mL, 0.5 mg / mL, and 1.0 mg / mL of leech polypeptide reduces lipofuscin deposition in nematodes.
[0009] Preferably, 0.1 mg / mL, 0.5 mg / mL, and 1.0 mg / mL of the leech polypeptide reduced the level of ROS in the nematode.
[0010] Preferably, 0.5 mg / mL of the leech polypeptide reduces the level of ROS in nematodes.
[0011] Therefore, the application of the above-mentioned leech polypeptide in whitening and anti-aging has the following beneficial effects:
[0012] 1. The tyrosinase inhibitory activity test showed that the inhibition rate was 59.65% at a concentration of 3.2 mg / mL, which showed significant tyrosinase inhibitory activity. 50 It is 0.58mg / mL.
[0013] 2. The determination of lipofuscin deposition in nematodes showed that the administration concentrations of 0.1 mg / mL, 0.5 mg / mL, and 1.0 mg / mL can all reduce lipofuscin deposition in nematodes.
[0014] 3. The ROS level in Caenorhabditis elegans was tested, and it was found that 0.5 mg / mL of leech polypeptide significantly reduced the ROS level in the nematode. BRIEF DESCRIPTION OF THE DRAWINGS
[0015] Figure 1 is the inhibition rate of tyrosinase by different concentrations of leech extract;
[0016] Figure 2 The results show the effects of different concentrations of leech polypeptide extract on lipofuscin levels in Caenorhabditis elegans.
[0017] Figure 3 The results show the effects of different concentrations of leech polypeptide extract on ROS levels in Caenorhabditis elegans. DETAILED DESCRIPTION
[0018] Example
[0019] 1 Materials and instruments
[0020] Sodium chloride (20221201, Tianjin Zhiyuan Chemical Reagent Co., Ltd.); high-speed refrigerated centrifuge (ThermoScientific); anhydrous ethanol (2023090, Fuchen (Tianjin) Chemical Reagent Co., Ltd.); 50 mL centrifuge tube (23209857, Beijing Lanjieke Technology Co., Ltd.); 60-90 ° C petroleum ether (20230601415, Tianjin Zhiyuan Chemical Reagent Co., Ltd.); PBS buffer (concentration: 0.2 mol / L, Shanghai Shangbao Biotechnology Co., Ltd.); tyrosinase (purity: 99.5%, batch number: 9002-10-2, Shanghai McLean Biochemical Technology Co., Ltd.); L-dopa (purity: 99.5%, batch number: 100170-202105, Shanghai McLean Biochemical Technology Co., Ltd.); arbutin (purity: 99.5%, batch number: 11195 1-202001, Shanghai Yuanye Biotechnology Co., Ltd.); tryptone, yeast extract, peptone (Thermo Fisher Oxoid); agar powder (Beijing Solebold Technology Co., Ltd.); cholesterol (Beijing Bio-Toda Technology Co., Ltd.); 5-fluorouracil (analytical grade, Shanghai Aladdin Biochemical Technology Co., Ltd.); sodium hypochlorite (analytical grade, Shanghai Aladdin Biochemical Technology Co., Ltd.); anhydrous calcium chloride, anhydrous magnesium sulfate, sodium hydroxide (analytical grade, Beijing Chemical Plant); dipotassium hydrogen phosphate, potassium dihydrogen phosphate, disodium hydrogen phosphate (analytical grade, Tianjin Damao Chemical Reagent Co., Ltd.); sodium hypochlorite solution (analytical grade, Shanghai Aladdin Biochemical Technology Co., Ltd.); 1-phenoxy-2-propanol (Shanghai McLean Biochemical Technology Co., Ltd.); H2DCFDA reactive oxygen species (ROS) fluorescent probe (Nanjing Jiancheng Bioengineering Institute). 1 / 100,000 electronic balance (BT125D, Satorious, Germany); biochemical incubator (SPX-250, Beijing Kewei Yongxing Instrument Co., Ltd.); vortex oscillator (VORTEX-7, Haimen Qilin Bell Instrument Manufacturing Co., Ltd.); dual-frequency CNC ultrasonic cleaner (KH-250, Kunshan Hechuang Ultrasonic Instrument Co., Ltd.); mini centrifuge (D1008, Dalong Xingchuang Experimental Instrument Co., Ltd.); vertical pressure steam sterilizer (YXQLS-100SII, Shanghai Boxun Industrial Co., Ltd. Medical Equipment Factory); fluorescent inverted microscope (D-LH / LC, Nikon Imaging Instrument Sales China Co., Ltd.); vacuum freeze dryer (LGJ-10, Beijing Songyuan Huaxing Technology Development Co., Ltd.); KQ5200 ultrasonic cleaner (Kunshan Ultrasonic Instrument Co., Ltd.); high-speed refrigerated centrifuge (Thermo Scientific).
[0021] Wild-type Caenorhabditis elegans N2 (C. Elegans wild-type) nematode strain; uracil leakage mutant Escherichia coli (Escherichia coli OP50); nematode strains and bacterial strains were purchased from CGC (Caenorhabditis Genetics Center).
[0022] 2 Experimental methods
[0023] 2.1 Extraction and preparation of leech polypeptide
[0024] Weigh an appropriate amount of Philippine leech, extract with a sodium chloride concentration of 4.3%, ultrasonic time of 4h, ultrasonic number of 2 times (2h+2h), liquid-to-solid ratio of 1:15, add pre-cooled anhydrous ethanol to the extract to an alcohol concentration of 60%, stand at 4℃ for 6h, and centrifuge at a speed of 8000r / min and a low temperature of 4℃ for 20min. Discard the centrifugal precipitate and retain the supernatant, repeat the centrifugation three times, combine the supernatants obtained from the three centrifugations, and freeze-dry to obtain the product.
[0025] 2.2 Tyrosinase inhibitory activity test
[0026] A 96-well plate was used for sample loading. 0.2 mol / L PBS buffer was used as the solvent. Tyrosinase was prepared to 100 U / mL and L-DOPA was prepared to 0.5 mg / mL. The experiment was divided into 4 groups: Group A was blank, containing 200 μL PBS; Group B was blank control, containing 100 μL PBS + 100 μL tyrosinase solution; Group C was test sample control, containing 100 μL PBS + 100 μL sample solution; Group D was test sample, containing 100 μL tyrosinase solution + 100 μL sample solution; the positive control was arbutin, containing 100 μL tyrosinase solution + 100 μL arbutin solution. The sample was incubated at room temperature for 30 minutes, then 100 μL L-DOPA was added and incubated for another 5 minutes. The absorbance (475 nm) was measured in a full-wavelength microplate reader. The experiment was repeated 3 times. The inhibition rate of tyrosinase was calculated according to formula (1), and the IC 50 value.
[0027]
[0028] 2.3 Synchronization of nematodes
[0029] Select a plate with good growth of nematodes, no pollution and a large number of adult worms in the egg-laying stage, rinse the nematodes into a 1.5mL centrifuge tube with M9 buffer, wait for them to settle to the bottom of the centrifuge tube, discard the supernatant, add 1mL nematode lysis solution, vortex for 7min, centrifuge at 5000r / min for 2min, and discard the supernatant. Then add 1mL M9 buffer, vortex for 30s, centrifuge at 5000r / min for 2min, repeat three times to fully wash the lysis solution, place the obtained eggs on a culture medium not coated with E.coli OP50, and transfer them to a culture medium containing E.coli OP50 when the eggs hatch to the L1 stage, and continue to culture in the incubator to the L4 stage for subsequent experiments.
[0030] 2.4 Determination of lipofuscin deposition in nematodes
[0031] The Caenorhabditis elegans synchronized to the L4 stage were transferred to blank and NGM medium with different drug concentrations (0.1 mg / mL, 0.5 mg / mL, 1.0 mg / mL). After 5 days of drug administration, the nematodes in each group were collected into a 1.5 mL centrifuge tube, the supernatant was discarded, and the prepared anesthetic was added. After the nematodes were anesthetized, they were placed on a slide and observed and photographed with a fluorescent inverted microscope (excitation wavelength 480 nm, emission wavelength 530 nm). The exposure time and intensity were fixed when taking pictures, and the data were calculated and analyzed using ImageJ software for fluorescence intensity in the nematodes. At least 30 nematodes were measured in each group. The experiment was repeated three times independently.
[0032] 2.5 Determination of ROS levels in nematodes
[0033] The Caenorhabditis elegans synchronized to the L4 stage were transferred to blank and NGM medium with different drug concentrations (0.1 mg / mL, 0.5 mg / mL, and 1.0 mg / mL). After 5 days of drug administration, the nematodes in each group were collected into a 1.5 mL centrifuge tube and washed three times with M9 buffer. The supernatant was discarded and 100 μL of H 2 DCFDA solution (20 μM) was placed in a 22°C incubator for 2 hours. After two hours, the cells were taken out and washed three times with M9 buffer, and the supernatant was discarded. During the experiment, the prepared anesthetic was added. After the nematodes were anesthetized, they were placed on a glass slide and observed and photographed using a fluorescent inverted microscope (excitation wavelength 480 nm, emission wavelength 530 nm). The exposure time and intensity were fixed when taking pictures, and the data were calculated and analyzed using Image J software for fluorescence intensity in the nematodes. At least 30 nematodes were measured in each group. The experiment was repeated three times independently.
[0034] 2.6 Statistical methods
[0035] Statistical analysis was performed using GraphPad Prism 9.0 software, and the results are expressed as mean ± standard deviation. If the data among multiple groups were in accordance with normal distribution and had equal variance, one-way analysis of variance (ANOVA) was used. If the data were not in accordance with normal distribution, the Wilcoxon rank sum test was used. The differences were considered statistically significant when P < 0.05.
[0036] 3 Results
[0037] 3.1 Tyrosinase inhibitory activity results
[0038] Table 1 shows the inhibitory ability of leech extract and arbutin on tyrosinase. Figure 1 is the inhibition rate of samples with different concentrations on tyrosinase. Arbutin solution was used as the positive control in the experiment. When the concentration was 3.2 mg / mL, its inhibition rate was 56.29%. IC 50 The tyrosinase inhibitory activity test of the leech polypeptide was carried out, and the inhibition rate was 59.65% at a concentration of 3.2 mg / mL, which showed significant tyrosinase inhibitory activity, IC 50 It is 0.58 mg / mL, which is better than the positive control (2.24 mg / mL).
[0039] Table 1 Inhibitory ability of leech extract and arbutin on tyrosinase
[0040]
[0041] 3.2 Effects of leech polypeptide on lipofuscin deposition in Caenorhabditis elegans
[0042] The results of the effects of different concentrations of leech polypeptide extract on lipofuscin levels in Caenorhabditis elegans are shown in Figure 2 Compared with the blank control group, the lipofuscin content in the nematodes was significantly reduced after drug treatment, and this difference was statistically significant.
[0043] 3.3 Effects of leech polypeptide on ROS levels in Caenorhabditis elegans
[0044] The results of the effects of different concentrations of leech polypeptide extract on the ROS level in Caenorhabditis elegans are shown in the figure below. Compared with the blank control group, the ROS content in the nematodes was reduced after drug treatment, and the ROS level in the nematodes was statistically significant after treatment with 0.5 mg / mL leech polypeptide.
[0045] Therefore, the present application provides the application of leech polypeptide in whitening and anti-aging. The tyrosinase inhibition activity test shows that the inhibition rate is 59.65% at a concentration of 3.2 mg / mL, which has significant tyrosinase inhibition activity, IC 50The concentration of 0.1mg / mL, 0.5mg / mL, and 1.0mg / mL of lipofuscin in nematodes was 0.58mg / mL. ... of lipofuscin in nematodes was 0.58mg / mL.
[0046] In the description of this specification, the description with reference to the terms "an experimental example", "example", "specific example", etc. means that the specific features, structures, materials or characteristics described in conjunction with the experimental example or example are included in at least one experimental example or example of the present invention. In this specification, the schematic representation of the above terms does not necessarily refer to the same experimental example or example. Moreover, the specific features, structures, materials or characteristics described can be combined in any one or more experimental examples or examples in a suitable manner.
[0047] Finally, it should be noted that the above experimental examples are only used to illustrate the technical solution of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred experimental examples, those skilled in the art should understand that they can still modify or replace the technical solution of the present invention with equivalents, and these modifications or equivalent replacements cannot cause the modified technical solution to deviate from the spirit and scope of the technical solution of the present invention.
Claims
1. Application of leech polypeptide in whitening and anti-aging.
2. The use of the leech polypeptide according to claim 1 in whitening and anti-aging, characterized in that: Leech polypeptide has tyrosinase inhibitory activity at a concentration of 1.8-6.4 mg / mL.
3. The use of the leech polypeptide according to claim 1 in whitening and anti-aging, characterized in that: Leech polypeptide has tyrosinase inhibitory activity at a concentration of 3.2 mg / mL.
4. The use of the leech polypeptide of claim 1 in whitening and anti-aging, characterized in that: Administration of leech polypeptide at concentrations of 0.1 mg / mL, 0.5 mg / mL, and 1.0 mg / mL reduced lipofuscin deposition in nematodes.
5. The use of the leech polypeptide of claim 1 in whitening and anti-aging, characterized in that: 0.1mg / mL, 0.5mg / mL, and 1.0mg / mL of leech polypeptide reduced the ROS level in nematodes.
6. The use of the leech polypeptide in whitening and anti-aging according to claim 1, characterized in that: 0.5 mg / mL of leech polypeptide reduced the level of ROS in nematodes.
